[Pathophysiology and Prognostic Factors of Autoimmune Encephalitis]

Area of Science:

• Neurology
• Immunology
• Neuroscience

Background:

• Autoimmune encephalitis (AE) encompasses a growing spectrum of neurological disorders.
• Clinical presentations range from epilepsy and movement disorders to psychosis.
• The pathophysiology and prognostic factors require further elucidation.

Purpose of the Study:

• To review the expanding landscape of autoimmune encephalitis.
• To discuss the etiological triggers and pathogenic mechanisms.
• To highlight key prognostic factors for patient outcomes.

Main Methods:

• Literature review of recent findings on autoimmune encephalitis.
• Analysis of etiological factors including tumors and infections (e.g., Herpes encephalitis).
• Examination of pathogenic mechanisms involving antibodies against neuronal surface epitopes.

Main Results:

• Diverse triggers identified, including tumors and CNS infections.
• Antibodies targeting neuronal surface epitopes are pathogenic, acting via receptor binding, internalization, blockage, or complement activation.
• Key prognostic factors include antibody type/titer (e.g., anti-NMDA, anti-GABA, anti-AMPA, VGKC-complex antibodies), associated tumors, immunotherapy efficacy, and biomarkers.

Conclusions:

• Autoimmune encephalitis is a complex condition with varied presentations and triggers.
• Antibody-mediated mechanisms are central to pathogenesis.
• Prognosis is influenced by specific antibody profiles, associated conditions, and therapeutic interventions, underscoring the importance of biomarkers.